Potentiation of the antidiuretic effect of vasopressin by chlorpropamide.
D000818:Animals; D002747:Chlorpropamide / Q000494:pharmacology* / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D004357:Drug Synergism; D005260:Female; D007030:Hypothalamo-Hypophyseal System / Q000002:abnormalities; D007671:Kidney Concentrating Ability / Q000187:drug effects; D008297:Male; D009994:Osmolar Concentration; D011188:Potassium / Q000652:urine; D051381:Rats; D012964:Sodium / Q000652:urine; D014556:Urine; D014667:Vasopressins / Q000494:pharmacology*
D014667:Vasopressins; D012964:Sodium; D011188:Potassium; D002747:Chlorpropamide